FAST NEWS: Livzon Pharma plans spinoff for reagent business
The latest: Livzon Pharmaceutical Group Inc. (1513.HK) announced on Friday it plans to spin off its Livzon Diagnostics unit, a diagnostic reagent and equipment manufacturer in which it holds a…
Recent Articles
RELATED ARTICLES
-
Hengrui Pharma accelerates bid for global brand status
600276.SHG -
Eshallgo looks skyward to cloud gaming to offset sputtering office business
EHGO.US
-
GDS moves closer to breakup with REIT spinoff plan
9698.HK GDS.US
- Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
- Huge Dental hopes Hong Kong smiles on its latest listing attempt
-
ACM Research straddles growing U.S.-China microchip divide
ACMR.US 688082.SHG
-
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
